Clinical Trial: Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07613047) titled 'Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix' on May 21.

Brief Summary: This investigator-initiated study will compare ADM and resorbable cross-linked collagen membrane barriers for guided bone regeneration at atrophic lateral ridge augmentation sites.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Acellular Dermal Matrix Bone Grafting Soft Tissue Grafting

Intervention: PROCEDURE: Guided Bone Regeneration with ADM (AlloDerm) as a barrier

GBR will be performed using a composite particulate graft consisting of a combination of freeze-dried bone al...